Detection of somatostatin receptors in human osteosarcoma

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Ionnou, Markos ^a   Papagelopoulos, Panayiotis J ^b   Papanastassiou, Ioannis ^a   Iakovidou, Ioanna ^a   Kottakis, Stamatios ^a   Demertzis, Nikolaos ^a  

^a Cancer Hospital   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; METHOTREXATE; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AMPUTATION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMB SALVAGE; MALE; OSTEOSARCOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; BIOSYNTHESIS; BONE TUMOR; METABOLISM; MIDDLE AGED; SURVIVAL;

ADOLESCENT; ADULT; BONE NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOSARCOMA; RECEPTORS, SOMATOSTATIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 52749097621     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-99     Document Type: Article

References (30)

1. Campanacci M Bone and soft tissue tumors: Clinical features, imaging, pathology and treatment Padova: Wein: Springer-Verlag 2 1999
2. Whelan JS Osteosarcoma Eur J Cancer 1997, 33:1611-1618 discussion 1618-1619 10.1016/S0959-8049(97)00251-7 9389923
3. Huvos AG Bone tumors: Diagnosis, treatment and prognosis Philadelphia; London: W.B. Saunders 2 1991
4. Bacci G Longhi A Versari M Mercuri M Briccoli A Picci P Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution Cancer 2006, 106:1154-1161 10.1002/cncr.21724 16421923
5. Cotterill SJ Wright CM Pearce MS Craft AW Stature of young people with malignant bone tumors Pediatr Blood Cancer 2004, 42:59-63 10.1002/ pbc.10437 14752796
6. James RA Dymock RB Osteosarcoma associated with acromegaly: A case report Pathology 1976, 8:157-159 10.3109/00313027609094442 1067559
7. Pizzo PA Poplack DG Principles and practice of pediatric oncology Philadelphia; London: Lippincott Williams & Wilkins 4 2001
8. Pinski J Schally AV Halmos G Szepeshazi K Groot K Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice Int J Cancer 1996, 65:870-874 10.1002/ (SICI)1097-0215(19960315)65:6<870::AID-IJC27>3.0.CO;2-6 8631606
9. Conzemius MG Graham JC Haynes JS Graham CA Effects of treatment with growth hormone and somatostatin on efficacy of diammine [1,1-cyclobutane dicarboxylato (2-)-0,0′]-(SP-4-2) in athymic rats with osteosarcoma Am J Vet Res 2000, 61:646-650 10.2460/ajvr.2000.61.646 10850839
10. Khanna C Prehn J Hayden D Cassaday RD Caylor J Jacob S Bose SM Hong SH Hewitt SM Helman LJ A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: Evaluation of insulin-like growth factor suppression and chemotherapy Clin Cancer Res 2002, 8:2406-2412 12114446
11. Koper JW Markstein R Kohler C Kwekkeboom DJ Avezaat CJ Lamberts SW Reubi JC Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth J Clin Endocrinol Metab 1992, 74:543-547 10.1210/jc.74.3.543 1346787
12. Ganz MB Pachter JA Barber DL Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP J Biol Chem 1990, 265:8989-8992 2160951
13. Reubi JC Laissue J Krenning E Lamberts SW Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications J Steroid Biochem Mol Biol 1992, 43:27-35 10.1016/ 0960-0760(92)90184-K 1356016
14. Daw NC Billups CA Rodriguez-Galindo C McCarville MB Rao BN Cain AM Jenkins JJ Neel MD Meyer WH Metastatic osteosarcoma Cancer 2006, 106:403-412 10.1002/cncr.21626 16353204
15. Meyers PA Heller G Healey J Huvos A Lane J Marcove R Applewhite A Vlamis V Rosen G Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience J Clin Oncol 1992, 10:5-15 1370176
16. Bacci G Ferrari S Mercuri M Longhi A Fabbri N Galletti S Forni C Balladelli A Serra M Picci P Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: Outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999 Acta Orthop 2007, 78:377-384 10.1080/17453670710013960 17611853
17. Alumets J Sundler F Hakanson R Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut Cell Tissue Res 1977, 185:465-479 10.1007/BF00220651 342100
18. Erlandsen SL Hegre OD Parsons JA McEvoy RC Elde RP Pancreatic islet cell hormones distribution of cell types in the islet and evidence for the presence of somatostatin and gastrin within the D cell J Histochem Cytochem 1976, 24:883-897 60437
19. Parsons JA Erlandsen SL Hegre OD McEvoy RC Elde RP Central and peripheral localization of somatostatin. Immunoenzyme immunocytochemical studies J Histochem Cytochem 1976, 24:872-882 60436
20. Srkalovic G Cai RZ Schally AV Evaluation of receptors for somatostatin in various tumors using different analogs J Clin Endocrinol Metab 1990, 70:661-669 1968467
21. Pinski J Schally AV Halmos G Szepeshazi K Groot K O'Byrne K Cai RZ Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice Br J Cancer 1994, 70:886-892 7947094
22. Enneking WF A system of staging musculoskeletal neoplasms Clin Orthop Relat Res 1986, 9-24 3456859
23. Bacci G Ferrari S Bertoni F Ruggieri P Picci P Longhi A Casadei R Fabbri N Forni C Versari M Campanacci M Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/ osteosarcoma-2 protocol: An updated report J Clin Oncol 2000, 18:4016-4027 11118462
24. Fuchs N Bielack SS Epler D Bieling P Delling G Korholz D Graf N Heise U Jurgens H Kotz R Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs Ann Oncol 1998, 9:893-899 10.1023/A:1008391103132 9789613
25. Provisor AJ Ettinger LJ Nachman JB Krailo MD Makley JT Yunis EJ Huvos AG Betcher DL Baum ES Kisker CT Miser JS Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group J Clin Oncol 1997, 15:76-84 8996127
26. Finkel MP Reilly CA Jr Biskis BO Pathogenesis of radiation and virus-induced bone tumors Recent Results Cancer Res 1976, 92-103 189372
27. Swaney JJ Familial osteogenic sarcoma Clin Orthop Relat Res 1973, 64-68 10.1097/00003086-197311000-00010 4521231
28. Guyton AC Hall JE Textbook of medical physiology Edinburgh: Elsevier Saunders; Oxford: Elsevier Science [distributor] 11 2006
29. Mansky PJ Liewehr DJ Steinberg SM Chrousos GP Avila NA Long L Bernstein D Mackall CL Hawkins DS Helman LJ Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: Significant reduction of insulin-like growth factor-1 serum levels J Pediatr Hematol Oncol 2002, 24:440-446 10.1097/00043426-200208000-00007 12218590
30. Ferrari S Dondi M Fanti S Zoboli S Giacomini S Mercuri M Bacci G Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma Cancer Biother Radiopharm 2003, 18:847-851 10.1089/108497803770418391 14629833